A citation-based method for searching scientific literature

J H Krystal, L P Karper, J P Seibyl, G K Freeman, R Delaney, J D Bremner, G R Heninger, M B Bowers, D S Charney. Arch Gen Psychiatry 1994
Times Cited: 2342







List of co-cited articles
998 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Recent advances in the phencyclidine model of schizophrenia.
D C Javitt, S R Zukin. Am J Psychiatry 1991
18

Antidepressant effects of ketamine in depressed patients.
R M Berman, A Cappiello, A Anand, D A Oren, G R Heninger, D S Charney, J H Krystal. Biol Psychiatry 2000
17

A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.
Carlos A Zarate, Jaskaran B Singh, Paul J Carlson, Nancy E Brutsche, Rezvan Ameli, David A Luckenbaugh, Dennis S Charney, Husseini K Manji. Arch Gen Psychiatry 2006
14


mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists.
Nanxin Li, Boyoung Lee, Rong-Jian Liu, Mounira Banasr, Jason M Dwyer, Masaaki Iwata, Xiao-Yuan Li, George Aghajanian, Ronald S Duman. Science 2010
12

The positive and negative syndrome scale (PANSS) for schizophrenia.
S R Kay, A Fiszbein, L A Opler. Schizophr Bull 1987
11

Mechanisms of ketamine action as an antidepressant.
P Zanos, T D Gould. Mol Psychiatry 2018
249
10

NMDAR inhibition-independent antidepressant actions of ketamine metabolites.
Panos Zanos, Ruin Moaddel, Patrick J Morris, Polymnia Georgiou, Jonathan Fischell, Greg I Elmer, Manickavasagom Alkondon, Peixiong Yuan, Heather J Pribut, Nagendra S Singh,[...]. Nature 2016
744
10

Ketamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics.
A K Malhotra, D A Pinals, C M Adler, I Elman, A Clifton, D Pickar, A Breier. Neuropsychopharmacology 1997
491
10

Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms.
Panos Zanos, Ruin Moaddel, Patrick J Morris, Lace M Riggs, Jaclyn N Highland, Polymnia Georgiou, Edna F R Pereira, Edson X Albuquerque, Craig J Thomas, Carlos A Zarate,[...]. Pharmacol Rev 2018
302
10

Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial.
James W Murrough, Dan V Iosifescu, Lee C Chang, Rayan K Al Jurdi, Charles E Green, Andrew M Perez, Syed Iqbal, Sarah Pillemer, Alexandra Foulkes, Asim Shah,[...]. Am J Psychiatry 2013
624
10

Ketamine: A Paradigm Shift for Depression Research and Treatment.
John H Krystal, Chadi G Abdallah, Gerard Sanacora, Dennis S Charney, Ronald S Duman. Neuron 2019
108
9

Glutamate and dopamine in schizophrenia: an update for the 21st century.
Oliver Howes, Rob McCutcheon, James Stone. J Psychopharmacol 2015
362
9

NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses.
Anita E Autry, Megumi Adachi, Elena Nosyreva, Elisa S Na, Maarten F Los, Peng-fei Cheng, Ege T Kavalali, Lisa M Monteggia. Nature 2011
9


Effects of ketamine in normal and schizophrenic volunteers.
A C Lahti, M A Weiler, B A Tamara Michaelidis, A Parwani, C A Tamminga. Neuropsychopharmacology 2001
438
9

NMDA receptor function and human cognition: the effects of ketamine in healthy volunteers.
A K Malhotra, D A Pinals, H Weingartner, K Sirocco, C D Missar, D Pickar, A Breier. Neuropsychopharmacology 1996
486
9

Nature of Glutamate Alterations in Schizophrenia: A Meta-analysis of Proton Magnetic Resonance Spectroscopy Studies.
Kate Merritt, Alice Egerton, Matthew J Kempton, Matthew J Taylor, Philip K McGuire. JAMA Psychiatry 2016
195
8

Abnormal neural oscillations and synchrony in schizophrenia.
Peter J Uhlhaas, Wolf Singer. Nat Rev Neurosci 2010
7


Acute and chronic effects of ketamine upon human memory: a review.
Celia J A Morgan, H Valerie Curran. Psychopharmacology (Berl) 2006
153
7




Acute effects of ketamine on memory systems and psychotic symptoms in healthy volunteers.
Celia J A Morgan, Ali Mofeez, Brigitta Brandner, Lesley Bromley, H Valerie Curran. Neuropsychopharmacology 2004
170
7

PHARMACOLOGIC EFFECTS OF CI-581, A NEW DISSOCIATIVE ANESTHETIC, IN MAN.
E F DOMINO, P CHODOFF, G CORSSEN. Clin Pharmacol Ther 1965
593
7

Ketamine and Other NMDA Antagonists: Early Clinical Trials and Possible Mechanisms in Depression.
D Jeffrey Newport, Linda L Carpenter, William M McDonald, James B Potash, Mauricio Tohen, Charles B Nemeroff. Am J Psychiatry 2015
322
7

Association of Ketamine With Psychiatric Symptoms and Implications for Its Therapeutic Use and for Understanding Schizophrenia: A Systematic Review and Meta-analysis.
Katherine Beck, Guy Hindley, Faith Borgan, Cedric Ginestet, Robert McCutcheon, Stefan Brugger, Naomi Driesen, Mohini Ranganathan, Deepak Cyril D'Souza, Matthew Taylor,[...]. JAMA Netw Open 2020
23
30

A Consensus Statement on the Use of Ketamine in the Treatment of Mood Disorders.
Gerard Sanacora, Mark A Frye, William McDonald, Sanjay J Mathew, Mason S Turner, Alan F Schatzberg, Paul Summergrad, Charles B Nemeroff. JAMA Psychiatry 2017
224
7

A critical role for NMDA receptors in parvalbumin interneurons for gamma rhythm induction and behavior.
M Carlén, K Meletis, J H Siegle, J A Cardin, K Futai, D Vierling-Claassen, C Rühlmann, S R Jones, K Deisseroth, M Sheng,[...]. Mol Psychiatry 2012
397
6

Glutamate receptor dysfunction and schizophrenia.
J W Olney, N B Farber. Arch Gen Psychiatry 1995
6




Subanesthetic doses of ketamine stimulate psychosis in schizophrenia.
A C Lahti, B Koffel, D LaPorte, C A Tamminga. Neuropsychopharmacology 1995
643
6

Taming the ketamine tiger. 1965.
Edward F Domino. Anesthesiology 2010
232
6

Ketamine use: a review.
Celia J A Morgan, H Valerie Curran. Addiction 2012
313
6

The neurobiology of psychedelic drugs: implications for the treatment of mood disorders.
Franz X Vollenweider, Michael Kometer. Nat Rev Neurosci 2010
284
6

Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors.
Sungho Maeng, Carlos A Zarate, Jing Du, Robert J Schloesser, Joseph McCammon, Guang Chen, Husseini K Manji. Biol Psychiatry 2008
792
6


Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants.
Ronald S Duman, George K Aghajanian, Gerard Sanacora, John H Krystal. Nat Med 2016
601
6

Oxidative stress-driven parvalbumin interneuron impairment as a common mechanism in models of schizophrenia.
P Steullet, J-H Cabungcal, J Coyle, M Didriksen, K Gill, A A Grace, T K Hensch, A-S LaMantia, L Lindemann, T M Maynard,[...]. Mol Psychiatry 2017
158
6

Animal models of schizophrenia.
C A Jones, D J G Watson, K C F Fone. Br J Pharmacol 2011
412
6

Synaptic dysfunction in depression: potential therapeutic targets.
Ronald S Duman, George K Aghajanian. Science 2012
711
6

Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies.
Patrick F Sullivan, Kenneth S Kendler, Michael C Neale. Arch Gen Psychiatry 2003
6

Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report.
A John Rush, Madhukar H Trivedi, Stephen R Wisniewski, Andrew A Nierenberg, Jonathan W Stewart, Diane Warden, George Niederehe, Michael E Thase, Philip W Lavori, Barry D Lebowitz,[...]. Am J Psychiatry 2006
6

NMDAR Hypofunction Animal Models of Schizophrenia.
Gloria Lee, Yi Zhou. Front Mol Neurosci 2019
33
18


Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia.
John E Lisman, Joseph T Coyle, Robert W Green, Daniel C Javitt, Francine M Benes, Stephan Heckers, Anthony A Grace. Trends Neurosci 2008
704
5

NMDA receptor hypofunction model of schizophrenia.
J W Olney, J W Newcomer, N B Farber. J Psychiatr Res 1999
699
5


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.